Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: WBA stock price vs M: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at M's multiple
Needs M P/S.
Implied fair value · at WBA's multiple
Needs WBA P/S.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
16 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
WALGREENS BOOTS ALLIANCE, INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Macy's, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
CVS HEALTH Corp
WBA vs CVS
Walmart Inc.
WBA vs WMT
KROGER CO
WBA vs KR
Cigna Group
WBA vs CI
UNITEDHEALTH GROUP INC
WBA vs UNH
TJX COMPANIES INC /DE/
WBA vs TJX
ROSS STORES, INC.
WBA vs ROST
KOHLS Corp
WBA vs KSS
NORDSTROM INC
WBA vs JWN
DILLARD'S, INC.
WBA vs DDS
Burlington Stores, Inc.
WBA vs BURL
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe WBA can convert its 6.2% revenue growth into sustained positive margins and returns, then consider the name; otherwise, M looks higher quality because it already shows positive net income, positive operating margin, and positive ROIC.
On a relative basis, M looks better supported by profitability and balance sheet metrics, while WBA’s weak margins and negative earnings make any P/S-based comparison look less attractive. The provided implied price of $50.44 is anchored to M P/S reference, but WBA does not show the operational quality needed to justify a premium framing.
Supporting Metrics
